Lai Wei

8.5k total citations
277 papers, 6.0k citations indexed

About

Lai Wei is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lai Wei has authored 277 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Oncology, 63 papers in Surgery and 53 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lai Wei's work include Cancer Immunotherapy and Biomarkers (33 papers), Lung Cancer Treatments and Mutations (22 papers) and Chronic Lymphocytic Leukemia Research (20 papers). Lai Wei is often cited by papers focused on Cancer Immunotherapy and Biomarkers (33 papers), Lung Cancer Treatments and Mutations (22 papers) and Chronic Lymphocytic Leukemia Research (20 papers). Lai Wei collaborates with scholars based in United States, China and Germany. Lai Wei's co-authors include Tanios Bekaii‐Saab, Michael V. Knopp, Mario Ammirati, Manisha H. Shah, Lawrence M. Pfeffer, John C. Byrd, Matthew D. Ringel, Zaibo Li, Ewa Jacewicz and Robert A. Fox and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Lai Wei

253 papers receiving 5.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Lai Wei 2.2k 1.3k 1.1k 949 896 277 6.0k
Giuliano Mariani 1.6k 0.7× 1.5k 1.2× 2.4k 2.2× 868 0.9× 1.1k 1.2× 462 12.1k
Stephen Y. Lai 2.7k 1.3× 1.9k 1.5× 2.0k 1.9× 767 0.8× 1.2k 1.3× 271 8.3k
Hiroshi Yoshida 2.1k 1.0× 3.0k 2.4× 1.3k 1.2× 714 0.8× 1.2k 1.4× 506 8.3k
Clemens Tempfer 1.9k 0.9× 1.9k 1.5× 2.1k 2.0× 1.3k 1.4× 419 0.5× 374 9.2k
Eric R. Siegel 1.7k 0.8× 2.3k 1.8× 895 0.8× 423 0.4× 317 0.4× 260 6.3k
Emilio Bombardieri 2.7k 1.2× 1.0k 0.8× 1.3k 1.2× 311 0.3× 772 0.9× 305 8.0k
Atsushi Kubo 1.8k 0.8× 3.4k 2.7× 2.3k 2.1× 829 0.9× 740 0.8× 335 10.0k
Stanley J. Goldsmith 2.4k 1.1× 1.2k 0.9× 1.5k 1.4× 462 0.5× 538 0.6× 223 9.2k
Hiroaki Kajiyama 2.4k 1.1× 3.2k 2.5× 920 0.9× 1.3k 1.4× 338 0.4× 423 10.3k
Masha Kocherginsky 1.8k 0.8× 1.7k 1.3× 903 0.8× 340 0.4× 250 0.3× 185 7.2k

Countries citing papers authored by Lai Wei

Since Specialization
Citations

This map shows the geographic impact of Lai Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lai Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lai Wei more than expected).

Fields of papers citing papers by Lai Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lai Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lai Wei. The network helps show where Lai Wei may publish in the future.

Co-authorship network of co-authors of Lai Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Lai Wei. A scholar is included among the top collaborators of Lai Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lai Wei. Lai Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Shushan, et al.. (2025). Evaluating the Efficacy of Tocilizumab for Steroid-Refractory Immune Checkpoint Inhibitor Pneumonitis. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A3109–A3109. 1 indexed citations
2.
Zhao, Wenrui, Quanlin An, Lei Wang, et al.. (2025). Novel cancer stem cell-targeted retinoid ZSH-512 impedes colorectal cancer progress via KDM3A-mediated epigenetic reprogramming. The Innovation. 6(4). 100831–100831. 1 indexed citations
3.
Zhao, Songzhu, Lai Wei, Joshua A. Englert, et al.. (2025). Cytokine profile of bronchoalveolar lavage in patients with and without checkpoint inhibitor pneumonitis. Cancer Immunology Immunotherapy. 74(2). 46–46.
4.
Wang, Henry E., Remle P. Crowe, J. Madison Hyer, et al.. (2024). Longitudinal Changes in Emergency Medical Services Advanced Airway Management. JAMA Network Open. 7(8). e2427763–e2427763. 3 indexed citations
5.
Fu, Mingwei, et al.. (2024). Comparing Microcrystal Electron Diffraction (MicroED) and X-ray crystallography as methods for structure determination of Oseltamivir phosphate. Journal of Molecular Structure. 1308. 138085–138085. 4 indexed citations
6.
Munroe, Elizabeth, Madison Hyer, William J. Meurer, et al.. (2024). High-Flow Nasal Cannula Versus Noninvasive Ventilation as Initial Treatment in Acute Hypoxia: A Propensity Score-Matched Study. Critical Care Explorations. 6(5). e1092–e1092. 2 indexed citations
7.
Konda, Bhavana, Eric J. Sherman, Erminia Massarelli, et al.. (2024). Cabozantinib Plus Ipilimumab/Nivolumab in Patients With Previously Treated Advanced Differentiated Thyroid Cancer. The Journal of Clinical Endocrinology & Metabolism. 110(3). 830–837. 4 indexed citations
8.
Fu, Mingwei, et al.. (2023). Novel pharmaceutical salt and solvates of rebamipide: Preparations, structural analysis and properties. Journal of Molecular Structure. 1288. 135786–135786. 4 indexed citations
9.
Wei, Lai, Hongjie Fan, Han Zhou, et al.. (2023). Development and Characterization of Fluorescent Probes for the G Protein-Coupled Receptor 35. ACS Medicinal Chemistry Letters. 14(4). 411–416. 6 indexed citations
10.
Wei, Lai, et al.. (2021). Risk factors for poor outcomes of spontaneous supratentorial cerebral hemorrhage after surgery. Journal of Neurology. 269(6). 3015–3025. 14 indexed citations
11.
Wu, Christina, Terence M. Williams, Ryan Robb, et al.. (2020). Phase I Trial of Trametinib with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer. Clinical Cancer Research. 26(13). 3117–3125. 13 indexed citations
12.
Sardesai, Sagar, Mohamed Badawi, Ewa Mrózek, et al.. (2020). A phase I study of an oral selective gamma secretase (GS) inhibitor RO4929097 in combination with neoadjuvant paclitaxel and carboplatin in triple negative breast cancer. Investigational New Drugs. 38(5). 1400–1410. 24 indexed citations
13.
Bekaii‐Saab, Tanios, Robert Wesolowski, Daniel H. Ahn, et al.. (2019). Phase I Immunotherapy Trial with Two Chimeric HER-2 B-Cell Peptide Vaccines Emulsified in Montanide ISA 720VG and Nor-MDP Adjuvant in Patients with Advanced Solid Tumors. Clinical Cancer Research. 25(12). 3495–3507. 54 indexed citations
14.
Özbay, İsa, Ali Cemal Yumuşakhuylu, Rishabh Sethia, et al.. (2017). One‐year quality of life and functional outcomes of transoral robotic surgery for carcinoma of unknown primary. Head & Neck. 39(8). 1596–1602. 16 indexed citations
15.
Awan, Farrukh T., Shanmugapriya Thangavadivel, David M. Weiss, et al.. (2017). A Phase 2 Trial of Early Intervention with Ibrutinib in Patients with Asymptomatic, High-Risk CLL. Blood. 130. 1748–1748. 1 indexed citations
16.
Mikhail, Sameh, Lai Wei, Mohamed E. Salem, & Tanios Bekaii‐Saab. (2016). Outcomes of definitive chemoradiation in patients with esophageal cancer. Diseases of the Esophagus. 30(2). 1–7. 18 indexed citations
17.
Kloos, Richard T., Matthew D. Ringel, Michael V. Knopp, et al.. (2009). Phase II Trial of Sorafenib in Metastatic Thyroid Cancer. Journal of Clinical Oncology. 27(10). 1675–1684. 430 indexed citations
18.
Wei, Lai. (2008). Spectral-based tests for periodicities. OhioLink ETD Center (Ohio Library and Information Network).
19.
Wei, Lai, Meiyun Fan, Lijing Xu, et al.. (2008). Bioinformatic Analysis Reveals cRel as a Regulator of a Subset of Interferon-Stimulated Genes. Journal of Interferon & Cytokine Research. 28(9). 541–552. 23 indexed citations
20.
Wei, Lai, et al.. (2003). Classic orthotopic liver transplantation without venovenous bypass: a report of 45 cases. Transplantation Proceedings. 35(1). 364–365. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giuliano Mariani Breakdown of academic impact, for papers by Stephen Y. Lai Breakdown of academic impact, for papers by Hiroshi Yoshida Breakdown of academic impact, for papers by Clemens Tempfer Breakdown of academic impact, for papers by Eric R. Siegel Breakdown of academic impact, for papers by Emilio Bombardieri Breakdown of academic impact, for papers by Atsushi Kubo Breakdown of academic impact, for papers by Stanley J. Goldsmith Breakdown of academic impact, for papers by Hiroaki Kajiyama Breakdown of academic impact, for papers by Masha Kocherginsky
Rankless by CCL
2026